Summary
- Current Price
- As of today, ADCT price is $4.18, up +1.95% on
- Current Price All-Time High
- ADCT price is currently -92.61% below its historical high of $56.59 set on
- Market Cap
- ADCT current market cap is $518M, up +229.42% over the past 365 days
- PE Ratio
- ADCT PE ratio is unknown
- Revenue
- ADCT current annual revenue is $70.84M, up +1.84% year-over-year
- Next Earnings
- The next earnings release for ADCT is on
Profile
| Metric | Value |
|---|---|
| Full Name | ADC Therapeutics SA |
| Ticker | NYSE: ADCT |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Switzerland |
| IPO | |
| Indexes | Not included |
| Website | adctherapeutics.com |
| Employees | 263 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $4.18 | ||
| Price, 1D Change | +1.95% | |
| $518M | ||
| - | ||
| - | ||
| 1.36 | ||
| $71M | ||
| Revenue, 1Y Change | +1.84% | |
| -$1.62 | ||
| EPS, 1Y Change | +44.70% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.62 | ||
| EPS Estimate | -$1.39 | |
| EPS Est. Change | +14.34% | |
| $70.84M | ||
| Revenue Estimate | $79.84M | |
| Revenue Est. Change | +12.71% | |
| $4.18 | ||
| Price Target | - | $8.00 |
| Price Tgt. Change | - | +91.39% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.39 | -$2.94 | -22.92% | |
| - | -$1.62 | - | |
| -$1.39 | N/A | +14.34% | |
| -$1.08 | N/A | +33.83% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $68.26M | $69.56M | +1.90% | |
| $72.84M | $70.84M | -2.75% | |
| $79.84M | N/A | +12.71% | |
| $80.68M | N/A | +13.90% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +162.89% | ||
| +33.12% | ||
| +229.42% | ||
| +104.49% | ||
| +1.84% | ||
| +108.85% | ||
| +44.70% | ||
| +45.80% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $4.18 | ||
| $3.54 | ||
| SMA 200 vs Price | -15.36% | |
| $3.81 | ||
| SMA 50 vs Price | -8.93% | |
| 1.36 | ||
| $0.25 | ||
| 55.63 | ||
| 56.52% | ||
| 87.15% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $70.84M | ||
| -$1.62 | ||
| $61.61M | ||
| 86.98% | ||
| -$130.65M | ||
| -184.44% | ||
| -$157.85M | ||
| -222.83% | ||
| -$127.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.61 | ||
| 3.82 | ||
| 3.59 | ||
| - | ||
| 3 | ||
| -6.17 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 6.88 | ||
| -2.17 | ||
| -6.17 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$202.64M | ||
| $250.87M | ||
| $321.98M | ||
| $307.39M | ||
| $524.62M | ||
| $80.47M | ||
| $123.00M | ||
| $1.37M | ||
| $18.03M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $228.68M | ||
| $192.27M | ||
| $9.23M | ||
| $85.91M | ||
| $3.28M | ||
| $0.00 | ||
| -$897.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$123.84M | ||
| -$867.00K | ||
| $97.05M | ||
| $867.00K | ||
| -$124.70M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| RBC Capital | → | |
| Guggenheim | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Cantor Fitzgerald | → | |
| Stephens & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ADCT
FAQ
What is the ticker symbol for ADC Therapeutics SA?
The ticker symbol for ADC Therapeutics SA is NYSE:ADCT
Does ADC Therapeutics SA pay dividends?
No, ADC Therapeutics SA does not pay dividends
What sector is ADC Therapeutics SA in?
ADC Therapeutics SA is in the Healthcare sector
What industry is ADC Therapeutics SA in?
ADC Therapeutics SA is in the Biotechnology industry
What country is ADC Therapeutics SA based in?
ADC Therapeutics SA is headquartered in Switzerland
When did ADC Therapeutics SA go public?
ADC Therapeutics SA initial public offering (IPO) was on May 18, 2020
Is ADC Therapeutics SA in the S&P 500?
No, ADC Therapeutics SA is not included in the S&P 500 index
Is ADC Therapeutics SA in the NASDAQ 100?
No, ADC Therapeutics SA is not included in the NASDAQ 100 index
Is ADC Therapeutics SA in the Dow Jones?
No, ADC Therapeutics SA is not included in the Dow Jones index
When was ADC Therapeutics SA last earnings report?
ADC Therapeutics SA's most recent earnings report was on November 10, 2025
When does ADC Therapeutics SA report earnings?
The next expected earnings date for ADC Therapeutics SA is April 2, 2026
Data Sources & References
- ADCT Official Website www.adctherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1771910/000162828025051095/0001628280-25-051095-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1771910/000162828025015131/0001628280-25-015131-index.htm
- ADCT Profile on Yahoo Finance finance.yahoo.com/quote/ADCT
- ADCT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/adct